Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

"My impression is that Bobby's comments were misinterpreted. He supports academic freedom also," NIH Director Bhattacharya says in response to portrayal that Secretary Kennedy undermined him.

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting II. This abstract does ...

BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will ...